Tag Archives: ALNY

Hot Biotech Stocks To Buy For 2018

Deals and Financings

China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing Growth Capital, focused on technology, media and entertainment, and Huaxing Healthcare. The company plans....More>>>

Best Biotech Stocks To Buy Right Now

On Tuesday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotechnology stock Threshold Pharmaceuticals (NASDAQ: THLD) as a long trade:

The chart below speaks for itself. After trying to work its way above a ceiling at $0.62 for the past several months, that finally happened today, in earnest. Better still, it’s happened after a strong foundation was laid,....More>>>

Best Biotech Stocks To Watch For 2018

What happened

Shares of Novavax, Inc. (NASDAQ:NVAX), a clinical-stage biotech developing vaccines, have risen about 10.7% as of 3:05 p.m. EDT on Thursday. A positive response to the company’s earnings pushed the stock up a couple days ago, but Thursday’s bump comes in response to recent insider share purchases.

So what

Earlier Thursday morning Novavax filed a....More>>>

Hot Biotech Stocks To Watch For 2019

Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin....More>>>

Top 5 Biotech Stocks To Invest In 2018

What happened

ImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it’s a biotech, so that’s often par for the course.

So what

One possibility is that day traders are just doing their thing, following the momentum, which pushes the stock price higher. We’ll know in a few days if the share price returns to previous levels.


Best Biotech Stocks To Own Right Now

With hundreds of biotech stocks on the market, who can keep up with them all? Probably no one. What happens as a result is that usually only the biggest biotechs (or the small biotechs getting bought by the biggest biotechs) get a lot of coverage.But sometimes those aren’t the stocks to watch most closely.

You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin....More>>>

Hot Biotech Stocks To Own Right Now

Investment company Parkside Investments, LLC buys iShares Core MSCI EAFE, Alerian MLP, SPDR Select Sector Fund – Consumer Discretionary, iShares Nasdaq Biotechnology Index Fund, Alibaba Group Holding, Platform Specialty Products Corp, SPDR S&P Oil & Gas Explor & Product, SPDR Nuveen Bloomberg Barclays Short Term Municipa, Citigroup Inc, Discovery Communications Inc, sells SPDR....More>>>

Top 10 Biotech Stocks To Buy Right Now

It has been over two years since I wrote Acceleron Pharma (XLRN) Has Two Potential Blockbusters, so an update is in order. Back then, on July 22, 2015, Acceleron closed at $32.18. It has been very volatile in the meantime, hitting $50.49 on December 29, 2015, but also $21.99 on October 13, 2015. That is part of the thrill (or opportunity, or danger) of investing in clinical-state biotechnology companies.....More>>>

Best Biotech Stocks To Own For 2018

Shares of Dynavax Technologies (DVAX) have fallen by 17% over the past three years. Year-to-date the stock is in the red by around 8% and is also currently our biggest laggard in the Core Biotech model account.

Long time readers are well aware that I believe the best investment ideas have an easily summarized thesis. Here is ours from the Core Biotech series:

HEPLISAV B appears to....More>>>

Top 5 Biotech Stocks To Watch For 2019

Media coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has trended somewhat positive on Wednesday, according to Accern Sentiment. The research firm identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable.....More>>>

Top 10 Biotech Stocks To Invest In 2018

Midway through trading Tuesday, the Dow traded down 0.13 percent to 24,258.53 while the NASDAQ climbed 0.56 percent to 6,813.36. The S&P also rose, gaining 0.10 percent to 2,642.13.

Leading and Lagging Sectors

On Tuesday, the information technology sector proved to be a source of strength for the market. Leading the sector was strength from Daqo New Energy Corp. (NYSE: DQ) and....More>>>

Top 10 Biotech Stocks To Invest In 2018

Last year, Gilead Sciences (NASDAQ:GILD) managed a feat that very few of its peers ever have (or probably ever will): It shed a staggering $40 billion in value without a single top-selling drug going off patent.

GILD Market Cap data by YCharts.

In fact, the biotech actually launched multiple new products last year, such as the HIV medsOdefsey and Descovy, along with the latest addition....More>>>

Top 5 Biotech Stocks For 2018

Welcome to the third edition in our new series, JF’s Core Biotech Buys.

Our model account utilizes a full position size of $5,000 and will hold up to 20 stocks. Trades will be less frequent with cost averages calculated at the day’s close when an article is published. Depending on the size of a reader’s account, buying or selling in smaller increments may be warranted or....More>>>

Top 10 Heal Care Stocks To Buy Right Now

What happened

SMART Global Holdings(NASDAQ:SGH)stock rose 43.5% in March, according to data provided byS&P Global Market Intelligence.

The stock gains correlated with SMART’s announcement that its executive chairman, Ajay Shah, would become the company’s new CEO, replacing Iain MacKenzie after a transitional period. This was followed by a strong second-quarter earnings....More>>>

Hot Biotech Stocks To Watch For 2019


Corcept Therapeutics (NASDAQ:CORT) is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit. Both guidance by the company and analyst coverage suggest substantial growth in earnings and revenue. While not without the inherent risks of investing in a small/mid-cap biotech companies,....More>>>